Challenges Faced by UnitedHealthcare and Insurers Amid Policy Changes

UnitedHealthcare, Aetna under CVS Health, Centene, and Blue Cross and Blue Shield plans operated by Elevance Health are observing a decline in patient claim costs. However, challenges loom for insurers offering government-subsidized health plans as changes in healthcare policy have led to some Americans discontinuing coverage.

UnitedHealthcare, a division of UnitedHealth Group, reported a first-quarter medical loss ratio under 85%, leading to a positive response from Wall Street and an increase in the company’s stock. For over two years, health insurers have faced escalating medical expenses, with medical loss ratios frequently exceeding 90%. Last year, UnitedHealthcare’s full-year adjusted medical care ratio was 88.9%, dipping from 85.5% the previous year. The first quarter of 2026 showed a drop to 83.9% from 84.8% in the first quarter of the previous year, attributed to effective medical cost management and favorable reserve developments despite steady utilization and cost trends.

Industry analysts warn of potential cost increases that could impede insurers' margin recovery efforts. Fitch Ratings noted elevated healthcare utilization trends, potential Medicaid risk pool changes, and the expiration of enhanced Premium Tax Credits as factors that might impact margins. The termination of these enhanced Obamacare tax credits has led to declining enrollments.

UnitedHealthcare’s enrollment fell from 1.7 million to 1.4 million, while Centene saw a decline from 5.54 million to 3.58 million. Elevance maintained steady enrollment at 1.4 million year-over-year. The withdrawal of these tax credits is prompting customers to either drop coverage or select less expensive plans with higher deductibles.

Notably, Cigna and CVS Health have exited specific market segments, decisions anticipated by industry analysts following political shifts leading to the non-extension of enhanced tax credits. The loss of these subsidies potentially increases out-of-pocket premiums for many Americans.

Initially, these subsidies aimed to make healthcare more affordable, with their expansion under the Inflation Reduction Act of 2022 boosting Obamacare enrollment to record levels. However, a reduction in insured populations could impact insurers’ business operations, pricing structures, and market geographies. Elevance Health highlighted these concerns in recent SEC filings, emphasizing the ACA's continuing effects on its business and operational outcomes.